PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has entered into a definitive agreement (the ...
NEW YORK, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Alpha Modus, Corp. (“Alpha Modus”), a technology company with a core focus on artificial intelligence in retail, and Insight Acquisition Corp. (INAQ), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results